Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.25B | $2.25B | $35.5M | $10.0M | $497.3M | $41.2M | $78.5M | $21.5M |
| Research & development | $1.36B | $983.4M | $859.5M | $663.4M | $580.5M | $370.9M | $220.8M | $83.6M |
| Operating expenses | $3.19B | $2.27B | $1.69B | $1.17B | $888.2M | $542.5M | $292.9M | — |
| Operating income | $1.05B | −$21.7M | −$425.0M | −$720.3M | −$348.7M | −$477.6M | −$198.9M | −$81.8M |
| Net income | $1.29B | $833.0M | −$295.1M | −$709.6M | −$408.3M | −$608.5M | −$181.2M | −$66.6M |
| Basic EPSper diluted share | $21.08 | $13.92 | -$5.16 | -$13.05 | -$7.99 | -$13.40 | -$4.69 | — |
| Diluted EPSper diluted share | $19.57 | $12.78 | -$5.16 | -$13.05 | -$7.99 | -$13.40 | -$4.69 | — |